The latest and most advanced radiosurgery system from Elekta will offer significantly faster-automated treatment planning for clinicians and more personalized and patient-friendly treatments.
Elekta doesn’t intend to rest on its laurels with its 50 years of real-world evidence in the field of intracranial surgery with the Leksell gamma knife. The company is branching out with its Esprit system.
Now, in a single platform, Esprit offers clinicians superior visualization, as well as remote accessibility and collaboration tools for the treatment team. With an accuracy of <0.3 mm, the company claims the system is precise enough to treat even the most challenging targets while delivering a gentler, more personalized approach to radiosurgery. Esprit features workflow options based on a single session, fractionated, adaptive, or stage protocols, in a system designed for end-to-end ease of use.
“Esprit will allow clinicians to take radiosurgery to the next level and treat patients with the highest accuracy, protecting their mind and memories and enabling a higher quality of life,” said Gustaf Salford, Elekta’s President and CEO, in a prepared statement.
Esprit was unveiled at the European Society for Radiotherapy and Oncology (ESTRO) 2022 on May 6.
Esprit is pending CE submission and is not available in all markets.